BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Echeverría N, Moratorio G, Cristina J, Moreno P. Hepatitis C virus genetic variability and evolution. World J Hepatol 2015; 7(6): 831-845 [PMID: 25937861 DOI: 10.4254/wjh.v7.i6.831]
URL: https://www.wjgnet.com/1948-5182/full/v7/i6/831.htm
Number Citing Articles
1
Lanhui Yang, Chenyan Jiang, Song Hu, Qiongni Diao, Jia Li, Wei Si, Mei Chen, Richard Zhao. Evolving Diversity of Hepatitis C Viruses in Yunnan Honghe, ChinaInternational Journal of Molecular Sciences 2016; 17(3): 403 doi: 10.3390/ijms17030403
2
Václav Vopálenský, Anas Khawaja, Luděk Rožnovský, Jakub Mrázek, Tomáš Mašek, Martin Pospíšek. Characterization of Hepatitis C Virus IRES Quasispecies – From the Individual to the PoolFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00731
3
Satoshi Kokura. Hyperthermic Oncology from Bench to Bedside2016; : 261 doi: 10.1007/978-981-10-0719-4_25
4
Evelyn Stelzl, Bernhard Haas, Bernd Bauer, Sherry Zhang, Ellen H. Fiss, Grantland Hillman, Aaron T. Hamilton, Rochak Mehta, Marintha L. Heil, Ed G. Marins, Brigitte I. Santner, Harald H. Kessler, Heiner Wedemeyer. First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencingPLOS ONE 2017; 12(7): e0181273 doi: 10.1371/journal.pone.0181273
5
Nikolai Bessonov, Gennady Bocharov, Andreas Meyerhans, Vladimir Popov, Vitaly Volpert. Existence and Dynamics of Strains in a Nonlocal Reaction-Diffusion Model of Viral EvolutionSIAM Journal on Applied Mathematics 2021; 81(1): 107 doi: 10.1137/19M1282234
6
Mohamed El-Mesery, Mohammed El-Mowafy, Abdelaziz Elgaml, Laila F. Youssef, Sally Y. Abed. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma PatientsJournal of Interferon & Cytokine Research 2017; 37(8): 342 doi: 10.1089/jir.2016.0128
7
Ilan S. Weisberg, Ira M. Jacobson. Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral TreatmentClinics in Liver Disease 2017; 21(4): 659 doi: 10.1016/j.cld.2017.06.007
8
Ana Ortega-Prieto, Marcus Dorner. Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionVaccines 2017; 5(3): 24 doi: 10.3390/vaccines5030024
9
Daniele Lapa, Anna Garbuglia, Maria Capobianchi, Paola Del Porto. Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?Cells 2019; 8(4): 305 doi: 10.3390/cells8040305
10
Waqas Gulzar, Zafar Niaz, Sami Ullah Mumtaz, Somia Iqtadar, Tayyeba Komal, Sajid AbaidUllah. Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3aPakistan BioMedical Journal 2019; 2(1) doi: 10.52229/pbmj.v2i1.28
11
Elisabetta Loggi, Ranka Vukotic, Fabio Conti, Stefano Gitto, Pietro Andreone. Gold standard assays for the monitoring of patients with chronic hepatitis CFuture Virology 2018; 13(8): 529 doi: 10.2217/fvl-2018-0032
12
Pauline Trémeaux, Alban Caporossi, Marie-Ange Thélu, Michael Blum, Vincent Leroy, Patrice Morand, Sylvie Larrat. Hepatitis C virus whole genome sequencing: Current methods/issues and future challengesCritical Reviews in Clinical Laboratory Sciences 2016; 53(5): 341 doi: 10.3109/10408363.2016.1163663
13
Dimas Alexandre Kliemann, Cristiane Valle Tovo, Ana Beatriz Gorini da Veiga, Angelo Alves de Mattos, Charles Wood. Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus databaseWorld Journal of Gastroenterology 2016; 22(40): 8910-8917 doi: 10.3748/wjg.v22.i40.8910
14
Caroline E. R. Rowell, Hana M. Dobrovolny. Energy Requirements for Loss of Viral InfectivityFood and Environmental Virology 2020; 12(4): 281 doi: 10.1007/s12560-020-09439-9
15
Kaho H. Tisthammer, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings. Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3aViruses 2021; 13(3): 511 doi: 10.3390/v13030511
16
Mengdi Qi, Mengmei Yang, Liangzi Xu, Chunli Ma, Pu Huang, Jing Sun, Jiandong Shi, Yunzhang Hu. Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019Virus Research 2021; 296: 198354 doi: 10.1016/j.virusres.2021.198354
17
Micaela Parra, Natalia Laufer, Julieta M. Manrique, Leandro R. Jones, Jorge Quarleri. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected PatientsBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1728456
18
Asad Zia, Muhammad Ali, Hafsa Aziz, Muhammad Zia, Zabta Khan Shinwari, Abida Raza. A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in PakistanInfectious Diseases of Poverty 2018; 7(1) doi: 10.1186/s40249-018-0386-7
19
Mohammad Amin Behzadi, Abdolvahab Alborzi, Gholamreza Pouladfar, Mehdi Dianatpour, Mazyar Ziyaeyan. Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression VectorJundishapur Journal of Microbiology 2015; 8(11) doi: 10.5812/jjm.27355
20
Bushra Khubaib, Muhammad Idrees, Zareen Fatima, Madiha Akram, Samia Afzal, Iram Amin, Muhammad Shahid, Muhammad Wasim. Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcomeJournal of Digestive Diseases 2017; 18(7): 404 doi: 10.1111/1751-2980.12497
21
Lily He, Rui Dong, Rong Lucy He, Stephen S.-T. Yau. Positional Correlation Natural Vector: A Novel Method for Genome ComparisonInternational Journal of Molecular Sciences 2020; 21(11): 3859 doi: 10.3390/ijms21113859
22
Miguel Angel Martinez, Sandra Franco. Antiviral Drug Discovery and DevelopmentAdvances in Experimental Medicine and Biology 2021; 1322: 139 doi: 10.1007/978-981-16-0267-2_6
23
Dana Elkhalifa, Israa Al-Hashimi, Ala-Eddin Al Moustafa, Ashraf Khalil. A comprehensive review on the antiviral activities of chalconesJournal of Drug Targeting 2021; 29(4): 403 doi: 10.1080/1061186X.2020.1853759
24
Mohammed El-Mowafy, Abdelaziz Elgaml, Mohamed El-Mesery, Salma Sultan, Tamer A. E. Ahmed, Ahmed I. Gomaa, Mahmoud Aly, Walid Mottawea. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus InfectionBiology 2021; 10(1): 55 doi: 10.3390/biology10010055
25
Miguel A. Minaya, Travis L. Jensen, Johannes B. Goll, Maria Korom, Sree H. Datla, Robert B. Belshe, Lynda A. Morrison, Richard M. Longnecker. Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent InfectionsJournal of Virology 2017; 91(23) doi: 10.1128/JVI.00942-17
26
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatmentsWorld Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
27
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
28
Seema Patel. In silico analysis of Hepatitis C virus (HCV) polyprotein domains and their comparison with other pathogens and allergens to gain insight on pathogenicity mechanismsComputational Biology and Chemistry 2016; 65: 91 doi: 10.1016/j.compbiolchem.2016.10.006
29
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in AmmanBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
30
P. Muñoz de Rueda, S. M. Jiménez-Ruiz, R. Quiles, E. J. Pavón-Castillero, J. A. Muñoz-Gámez, J. Casado, A. Gila, A. Ruiz-Extremera, J. Salmerón. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune responseScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15605-0
31
Shantanu Prakash, Suruchi Shukla, Vangala Ramakrishna, Amita Jain. Distribution of hepatitis C genotypes in Uttar Pradesh, India; rare genotype 4 detectedJournal of Medical Virology 2018; 90(12): 1875 doi: 10.1002/jmv.25277
32
Hisashi Nakayama, Tadatoshi Takayama. Management before hepatectomy for hepatocellular carcinoma with cirrhosisWorld Journal of Hepatology 2015; 7(20): 2292-2302 doi: 10.4254/wjh.v7.i20.2292
33
Anton Eliseev, Keylie M. Gibson, Pavel Avdeyev, Dmitry Novik, Matthew L. Bendall, Marcos Pérez-Losada, Nikita Alexeev, Keith A. Crandall. Evaluation of haplotype callers for next-generation sequencing of virusesInfection, Genetics and Evolution 2020; 82: 104277 doi: 10.1016/j.meegid.2020.104277
34
Wei Zhan, Manish Muhuri, Phillip W. L. Tai, Guangping Gao. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.673699
35
Kimia Kamelian, Vincent Montoya, Andrea Olmstead, Winnie Dong, Richard Harrigan, Muhammad Morshed, Jeffrey B. Joy. Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methodsScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52613-8
36
Joel Henrique Ellwanger, Valéria de Lima Kaminski, Jacqueline María Valverde-Villegas, Daniel Simon, Vagner Ricardo Lunge, José Artur Bogo Chies. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is comingInfection, Genetics and Evolution 2018; 66: 376 doi: 10.1016/j.meegid.2017.08.011
37
Letitia Shunmugam, Mahmoud E. S. Soliman. Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibitionRSC Advances 2018; 8(73): 42210 doi: 10.1039/C8RA07346E
38
Chin Pok Chan, Haruka Uemura, Tsz Ho Kwan, Ngai Sze Wong, Shinichi Oka, Denise Pui Chung Chan, Shui Shan Lee. Review on the molecular epidemiology of sexually acquired hepatitis C virus infection in the Asia‐Pacific regionJournal of the International AIDS Society 2020; 23(9) doi: 10.1002/jia2.25618
39
Noriyuki Watanabe, Takaya Suzuki, Tomoko Date, Hussein Aly Hussan, Su Su Hmwe, Hideki Aizaki, Masaya Sugiyama, Masashi Mizokami, William Delaney IV, Guofeng Cheng, Masamichi Muramatsu, Takaji Wakita. Establishment of infectious genotype 4 cell culture-derived hepatitis C virus Journal of General Virology 2020; 101(2): 188 doi: 10.1099/jgv.0.001378
40
Luis Antonio Uribe-Noguez, José Antonio Mata-Marín, Alicia Ocaña-Mondragón, Ericka Nelly Pompa-Mera, Rosa María Ribas-Aparicio, Carla Ileana Arroyo-Anduiza, María Elena Gomez-Torres, Alberto Chaparro-Sánchez, Jesus Gaytán-Martínez, Stefan Mauss. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in MexicoJournal of Infection and Chemotherapy 2020; 26(2): 205 doi: 10.1016/j.jiac.2019.08.009
41
Mohamed El-Mesery, Mohammed El-Mowafy, Laila F. Youssef, Ahmed El-Mesery, Sally Yussef Abed, Abdelaziz Elgaml. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected PatientsJournal of Interferon & Cytokine Research 2021; 41(2): 52 doi: 10.1089/jir.2020.0118
42
Sobia Manzoor, Umair Akhtar, Sidrah Naseem, Madiha Khalid, Misha Mazhar, Fahed Parvaiz, Saba Khaliq. Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus InfectionViral Immunology 2016; 29(7): 401 doi: 10.1089/vim.2016.0008
43
Pantazis I. Theotokis, Louise Usher, Christopher K. Kortschak, Ed Schwalbe, Sterghios A. Moschos. Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAsMolecular Therapy - Nucleic Acids 2017; 9: 22 doi: 10.1016/j.omtn.2017.08.010
44
Vincent Montoya, Anita Y. M. Howe, Weiyan Y. Dong, Winnie Dong, Chanson J. Brumme, Andrea D. Olmstead, Kanna Hayashi, P. Richard Harrigan, Jeffrey B. Joy. Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88132-8
45
Amina Gul, Nabeela Zahid, Jawad Ahmed, Fazli Zahir, Imtiaz Ali Khan, Ijaz Ali. Molecular characterization of Hepatitis C virus 3a in PeshawarBMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1488-0
46
Guillermo A. Ortiz, Hirsh D. Trivedi, Claudia Nader. Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantationHemodialysis International 2018; 22: S22 doi: 10.1111/hdi.12648
47
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America2017; : 333 doi: 10.1007/978-3-319-54567-7_17
48
Taiki Yamashita, Haruhiko Takeda, Atsushi Takai, Soichi Arasawa, Fumiyasu Nakamura, Yoichi Mashimo, Miyuki Hozan, Shigeru Ohtsuru, Hiroshi Seno, Yoshihide Ueda, Akihiro Sekine. Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genomeScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59397-2
49
Geon-Woo Kim, Aleem Siddiqui. N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognitionProceedings of the National Academy of Sciences 2021; 118(10): e2022024118 doi: 10.1073/pnas.2022024118
50
Anders Boyd, Léa Duchesne, Karine Lacombe. Research gaps in viral hepatitisJournal of the International AIDS Society 2018; 21: e25054 doi: 10.1002/jia2.25054
51
Svitlana I. Romaniuk, Serhiy V. Komisarenko. OW THE HEPATITIS C VIRUS WAS DISCOVERED, OR THE DETECTIVE SEARCHES OF VIROLOGISTS FOR THE SILENT KILLERVisnik Nacional'noi' academii' nauk Ukrai'ni 2020; (12): 3 doi: 10.15407/visn2020.12.003
52
Hadas Dvory‐Sobol, Bin Han, Julia Lu, Mei Yu, Rudolf K. Beran, Guofeng Cheng, Ross Martin, Evguenia Svarovskaia, Hongmei Mo. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6Journal of Viral Hepatitis 2019;  doi: 10.1111/jvh.13116
53
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions inNS3,NS5A,andNS5BgenesReviews in Medical Virology 2020; 30(4) doi: 10.1002/rmv.2120
54
Nobuyuki Kato. Hepatitis C virus (HCV):Diversity and variation of RNA genomeOkayama Igakkai Zasshi (Journal of Okayama Medical Association) 2020; 132(2): 60 doi: 10.4044/joma.132.60
55
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and ProspectsVaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
56
Arun K. Bhunia. Foodborne Microbial PathogensFood Science Text Series 2018; : 133 doi: 10.1007/978-1-4939-7349-1_6
57
Julia Durzyńska, Anna Goździcka-Józefiak. Viruses and cells intertwined since the dawn of evolutionVirology Journal 2015; 12(1) doi: 10.1186/s12985-015-0400-7
58
Darrick K. Li, Raymond T. Chung. Hepatitis C Virus ProtocolsMethods in Molecular Biology 2019; 1911: 3 doi: 10.1007/978-1-4939-8976-8_1